Juan Pablo Rojas Hernández

Juan Pablo Rojas Hernández

Auto-generated profile, based on publicly available information

Juan Pablo Rojas Hernández

Universidad Libre Seccional Cali; Universidad del Valle

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
JCJaime E. Castellanos
Jaime E. Castellanos
NJNayeli Jaimes
Nayeli Jaimes
CCCarolina Coronel-Ruiza
Carolina Coronel-Ruiza
JRJuan Pablo Rojas
Juan Pablo Rojas
LMLuis F. Mejía
Luis F. Mejía
MVMyriam L. Velandia-Romero
Myriam L. Velandia-Romero
To identify the arbovirus involved in febrile cases identified in a pediatric clinic in Cali, Valle del Cauca province, Colombia, and study the clinical characteristics. A descriptive, prospective study enrolled 345 febrile children for 12 months in a pediatric clinic. Medical record registers documenting signs and symptoms, and serum samples were analyzed to detect DENV, CHIKV, and ZIKV by reverse transcription-polymerase chain reaction and serology methods. Diagnosis at the time of admission and discharge were compared based on laboratory test results. All patients were diagnosed as severe dengue at admission. Molecular detection and serology tests identified 143 CHIKV-positive (41.4%), 20 DENV-positive (5.8%), and 123 DENV-CHIKV coinfection patients (35.7%). DENV or CHIKV serology test results of these double-infected patients yield poor performance to confirm patient cases. ZIKV infection was detected in 5 patients (1.4%), every time as double or triple infections. . A sustained CHIKV circulation and transmission was confirmed causing febrile illness in children and indicating that this virus spreads even during the regular DENV season, leading to double infections and altering clinical symptoms. Specific clinical tests are necessary to closely identify the arbovirus involved in causing infectious diseases that can help in better treatment and mosquito-transmitted virus surveillance.

1 January 2016 in Revista chilena de pediatría
Verified
Journal Article
Open access
JRJuan Pablo Rojas
Juan Pablo Rojas
ALAura Lucia Leal
Aura Lucia Leal
JPJaime Patiño
Jaime Patiño
AMAnita Montañez
Anita Montañez
CGCamacho-Moreno Germán
Camacho-Moreno Germán
NRNicolás Ramos
Nicolás Ramos
Streptococcus pneumoniae (S. pneumoniae), also known as pneumococcus, is one of the main bacteria associated with mortality in children under 2 years of age, with a morbidity and mortality incidence that varies according to demographics and exposure to risk, or protective factors. To describe the child mortality due to invasive pneumococcal disease (IPD) between 2008 -2014 (6 years), in 8 Medical Centres in Bogotá, Colombia. Descriptive observational case series of patients who died of IPD, aged 28 days to 18 years, in 8 tertiary care institutions in Bogota, Colombia. The study period was from 1 January 2008 to 15 January 2014. 239 patients. A total of 239 registered cases of IPD were reviewed, showing a mortality of 8% (n 18). The mean age of patients that died was 43.7 months, with an age range from 2 to 176 months (14 years), with 66% of the cases being male. Serotypes were identified in 8 patients, finding: 6A, 6B, 10A, 14, 18C, 23B, 23F, and 35B. The most common clinical presentation of the cases was meningitis with mortality of 33% (6 cases), followed by bacteraemia without focus in 28% (5 cases), and pneumonia with 27% (5 cases). Combined clinical situations were presented, such as pneumonia and meningitis in 11% (2 cases). Two of the patients had clearly documented risk factors for IPD (asplenia and chronic respiratory disease). IPD mortality is particularly high in children under 2 years in male patients, especially when presented with a meningeal focus (44%). Serotyping was not possible in all patients who died, since no strain isolated was sent to the National Institute of Health. Continuous and systematic vigilance is required to evaluate the impact of vaccination and possible changes in the pattern of presentation of disease.

5 May 2020 in Interdisciplinary Journal of Epidemiology and Public Health
Verified
Journal Article
Open access
PDF file
JAJulieth Fernanda Urbano Arcos
Julieth Fernanda Urbano Arcos
ILIsabel Ruiz Ponce de Leon
Isabel Ruiz Ponce de Leon
OOOskar Andrey Oliveros
Oskar Andrey Oliveros
LRLuis Fernando Mejia Rivera
Luis Fernando Mejia Rivera
JHJuan Pablo Rojas Hernandez
Juan Pablo Rojas Hernandez
Introduction: Coronavirus until 1930 were part of the viruses that only disturbed the animal niche. Severe acute respiratory syndrome due to coronavirus 2 (SARS-CoV-2) a type of coronavirus that causes coronavirus disease (COVID-19); In the last year it has become a concern for international public health due to the triggered pandemic, due to its high transmissibility and high mortality that it has caused. Objective: describe SARS-COV-2 infection in pediatrics with special emphasis on virological, epidemiological aspects, transmission mechanism, clinical manifestations, and expectations of treatment in pediatric age. Methods: A review of articles in Spanish and English was made, using valid terms, on the PubMed, ScienceDirect and Medline databases related to the disease. Articles with a publication period of no more than 5 years were considered. Results: The epidemiology, pathophysiology, clinical manifestations, complications, isolation and possibilities of treatment of SARS-CoV-2 in pediatric age are described. Conclusions: SARS-CoV-2 is highly contagious, the pediatric population has mostly mild clinical manifestations. The importance of an appropriate approach in this population is to avoid spreading to other ages of greater morbidity and mortality and possible associated complications.

6 September 2020 in Infectio
Verified
Journal Article
Open access
PDF file
JMJuliana Mejía-Mertel
Juliana Mejía-Mertel
NGNicolás Gómez-Banoy
Nicolás Gómez-Banoy
JRJuan Pablo Rojas-Hernández
Juan Pablo Rojas-Hernández
EGEduardo Gotuzzo-Herencia
Eduardo Gotuzzo-Herencia
The Human T-lymphotropic virus type 1 (HTLV-1), a retrovirus with oncogenic properties, affects around ten to twenty million people worldwide. The most common disorders associated with HTLV-1 infection are T-cell leukemia/lymphoma (ALT) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Studies have reported other clinical manifestations in HTLV-1 seropositive patients, including inflammatory disorders, co-infections with opportunistic agents, and pulmonary diseases. Objective: Here, we aim to describe a cohort of juvenile patients with confirmed HTLV-1 infection that showed clinical manifestations other than neurological symptoms. Methodology and patients: Retrospective analysis of clinical data describing background and clinical findings of 12 juvenile patients with confirmed HTLV-1 infection, attended during January 2018 to February 2020 in a pediatric referral hospital in Cali, Colombia. Results: 11 out 12 patients were from Colombia´s Pacific coast, 10 suffered from significant nutritional deficiencies. Six exhibited dermatological findings, 3 compatible with infective dermatitis. None of the cases exhibited clinical or laboratory findings suggesting ALT or HAM/TPS. Eight patients had structural lung disease assessed by chest Computed Tomography (CT) scans; 4 of them tested positive for galactomannan antigen in bronchoalveolar fluid suggesting pulmonary aspergillosis, and 2 others exhibited a positive PCR testing for tuberculosis. Three patients were diagnosed with autoimmune disorders; 1 patient with Crohn´s Diseases, 1 case of autoimmune thrombocytopenic purpura, and a patient with Vogt-Koyanagi-Harada syndrome (non-granulomatous uveitis). Conclusions: There is a broad range of clinical manifestations in pediatric HTLV-1 patients, and the clinician should consider structural pulmonary disease, opportunistic co-infections and autoimmune disorders in the diagnostic algorithm.

22 October 2020 in CES Medicina
Verified
Journal Article
Closed access
PDF file
JHJuan Pablo Rojas Hernández
Juan Pablo Rojas Hernández
SBSindy Paola Bula
Sindy Paola Bula
VHVicky Cárdenas Hernández
Vicky Cárdenas Hernández
RLRobinson Pacheco López
Robinson Pacheco López
RSRodrigo Alberto Álzate Sánchez
Rodrigo Alberto Álzate Sánchez
Introducción: El dengue es la arbovirosis de propagación más rápida en todo el mundo; anualmente 390 millones de personas son infectadas. Objetivo: Identificar las manifestaciones clínicas y características demográficas asociadas a ingreso a unidad de cuidados intensivos en una institución pediátrica de Cali, Colombia, entre enero 2015 y diciembre 2016. Materiales y métodos: Estudio de casos y controles anidado en una cohorte. Caso: paciente mayor de 28 días y menor de 18 años, hospitalizado en la unidad de cuidados intensivos pediátricos con diagnóstico confirmado de dengue con signos de alarma o dengue grave, sumado a serología positiva para IgM y/o NS1. Control: paciente de igual edad y diagnóstico confirmado de dengue, sin ingreso a la unidad de cuidas intensivos.Resultados: Se evaluaron 24 casos y 176 controles, la mediana de edad en meses fue 142 vs.106 (RIC: 59-142). El 83 % procedía del área de urbana de Cali y 53 % era de sexo masculino. Presentar derrame pleural OR 3,4 (IC 1,2-9,8) y alteraciones cardiovasculares OR 4,7 (IC 1,7-13,1), incrementaron la probabilidad de ingreso a unidad de cuidados intensivos pediátricos. Tres pacientes fallecieron, todos pertenecían al grupo de casos. Conclusiones: El dengue en población pediátrica tiene un comportamiento clínico in específico; sin embargo, identificar derrame pleural o alteraciones cardiovasculares pueden explicar un ingreso a unidad de cuidados intensivos pediátricos y alertar sobre un posible desenlace fatal.

1 February 2014 in Revista chilena de pediatría
Verified
Journal Article
Open access
PDF file
JHJuan Pablo Rojas H
Juan Pablo Rojas H
MMMaría DEL Pilar Gómez M
María DEL Pilar Gómez M